Dantrium IV
Dantrium® Intravenous
(dantrolene sodium) for Injection
DRUG DESCRIPTION
Dantrium Intravenous is a sterile, non-pyrogenic, lyophilized formulation of dantrolene sodium for injection. Dantrium Intravenous is supplied in 70 mL vials containing 20 mg dantrolene sodium, 3000 mg mannitol, and sufficient sodium hydroxide to yield a pH of approximately 9.5 when reconstituted with 60 mL sterile water for injection USP (without a bacteriostatic agent).
Dantrium is classified as a direct-acting skeletal muscle relaxant. Chemically, Dantrium is hydrated 1-[[[5-(4-nitrophenyl)-2-furanyl]methylene]amino]-2,4-imidazolidinedione sodium salt. The structural formula for the hydrated salt is:
 |
The hydrated salt contains approximately 15% water (3-½ moles) and has a molecular weight of 399. The anhydrous salt (dantrolene) has a molecular weight of 336.
Generic Name: Dantrolene Sodium for Injection
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.
Health Extras
That Aching Back
We’ve all had the occasional backache, but when does it deserve a trip to the doctor? See more WebMD Videos »
Dantrium IV
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.